| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 06/22/2006 | US20060135527 Use of imatinib (glivec,sti-571) to inhibit breast cancer resistance protein (bcrp)-mediated resistance to therapeutic agents |
| 06/22/2006 | US20060135521 Administering racemic reboxetine or a salt thereof for inhibition of norepinephrine reuptake |
| 06/22/2006 | US20060135520 Method of treating peripheral neuropathy |
| 06/22/2006 | US20060135513 Methods of treating tumors |
| 06/22/2006 | US20060135508 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/22/2006 | US20060135506 Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders |
| 06/22/2006 | US20060135471 Anti-obesity compositions |
| 06/22/2006 | US20060135469 Separate type medical material |
| 06/22/2006 | US20060135464 Anti-infective compositions, methods and systems for treating pathogen-induced disordered tissues |
| 06/22/2006 | US20060135458 For use as therapeutic agents in viral infections by human and animal viruses and in cancers caused by oncogene viruses |
| 06/22/2006 | US20060135454 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 06/22/2006 | US20060135435 Agent that retards transformation of hormone-dependent cancer to non-hormone-dependent cancer |
| 06/22/2006 | US20060135417 Use of the crh (corticotropin releasing hormone)-ucn (urocortin) system in the treatment of inflammatory diseases |
| 06/22/2006 | US20060135415 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/22/2006 | US20060135403 Therapeutic formulations for the treatment of beta-amyloid related diseases |
| 06/22/2006 | US20060134782 Differentiated cells suitable for human therapy |
| 06/22/2006 | US20060134767 Mitotic kinesin binding site |
| 06/22/2006 | US20060134688 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
| 06/22/2006 | US20060134668 Methods for treating patients and identifying therapeutics |
| 06/22/2006 | US20060134286 Gallocatechin gallate-containing composition |
| 06/22/2006 | US20060134247 With soluble fiber of Musa spp. fruit such as plantains or bananas |
| 06/22/2006 | US20060134206 Oral compositions for treatment of diseases |
| 06/22/2006 | US20060134205 Process for preparing a pharmaceutical composition |
| 06/22/2006 | US20060134186 Oxygenating agents for enhancing host responses to microbial infections |
| 06/22/2006 | US20060134184 At least partially degradable films containing an active ingredient and method for the production of composition comprising an active compound |
| 06/22/2006 | US20060134117 Preventives/remedies for cancer |
| 06/22/2006 | US20060134115 Method of screening for sensitivity to kinase inhibitor therapy |
| 06/22/2006 | US20060134113 Preventive or therapeutic agent for sensitized T cell-mediated diseases comprising IL-6 antagonist as an active ingredient |
| 06/22/2006 | US20060134095 Antioxidative composition and composition for external use |
| 06/22/2006 | US20060134091 Additive for an animal feed |
| 06/22/2006 | US20060134090 Method and dietary composition for improving lipid digestibility |
| 06/22/2006 | US20060134062 Polymeric boronic acid derivatives as lipase inhibitors |
| 06/22/2006 | US20060134011 Oral and dental composition |
| 06/22/2006 | CA2594987A1 Therapeutic agent for constipation |
| 06/22/2006 | CA2591416A1 Medicinal composition containing fbpase inhibitor |
| 06/22/2006 | CA2591399A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | CA2590903A1 Compositions comprising pde4 modulators and their use for the treatment or prevention of airway inflammation |
| 06/22/2006 | CA2590883A1 Medicinal composition for treating diabetes |
| 06/22/2006 | CA2590838A1 Preventive or therapeutic agent for sleep disorder |
| 06/22/2006 | CA2590431A1 Novel pharmaceutical composition containing at least one dolastatin 10 derivative |
| 06/22/2006 | CA2590287A1 Combination of a glycine transporter (glyt1) inhibitor and an antipsychotic for the treatment of symptoms of schizophrenia as well as its preparation and use thereof |
| 06/22/2006 | CA2590278A1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and hmg coa reductase inhibitors |
| 06/22/2006 | CA2590211A1 Oral treatment compositions containing an anti-adhesion agent, antibacterial agent and incompatible compound |
| 06/21/2006 | EP1672368A1 Diagnostic and therapeutic epitope and transgenic plant |
| 06/21/2006 | EP1672062A1 Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in preventing and/or treating proliferative diseases causing sclerosis |
| 06/21/2006 | EP1671962A1 Novel fused heterocyclic compound and use thereof |
| 06/21/2006 | EP1671654A2 Conjugates of hydroxyalkyl starch and an active agent |
| 06/21/2006 | EP1671651A1 Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonists |
| 06/21/2006 | EP1671650A1 Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications |
| 06/21/2006 | EP1671649A1 Remedy for diabetes |
| 06/21/2006 | EP1671648A1 Prevention and treatment for gvhd |
| 06/21/2006 | EP1671647A1 Medicament for treating cancer |
| 06/21/2006 | EP1671641A1 Remedy and therapeutic method for periodontal diseases and pulpal diseases |
| 06/21/2006 | EP1671639A1 Treatment of acquired immunedeficiency syndrome AIDS with a combination therapy including curdlan sulphate |
| 06/21/2006 | EP1671637A2 Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 06/21/2006 | EP1671632A1 Pharmaceutical combination of angiotensin II antagonists and ACE inhibitors |
| 06/21/2006 | EP1671628A1 Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction |
| 06/21/2006 | EP1670551A1 Combination of phenylcarboxamides with beta-adrenergic receptor blockers and use thereof for the treatment of atrial arrhythmias |
| 06/21/2006 | EP1670526A2 Apparatus and method for administering a therapeutic agent |
| 06/21/2006 | EP1670514A2 Antitumor agent comprising a histone deacetylase inhibitor and a topoisomerase ii inhibitor |
| 06/21/2006 | EP1670513A2 Use of cox-2 inhibitor to prevent t-cell anergy induced by dendritic cell therapy |
| 06/21/2006 | EP1670489A1 Use of xenon with hypothermia for treating neonatal asphyxia |
| 06/21/2006 | EP1670483A1 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators |
| 06/21/2006 | EP1670465A1 Ocular solutions containing a macrolide antibiotic and/or mycophenolic acid |
| 06/21/2006 | EP1670449A2 Thyroid hormone analogs and methods of use in angiogenesis |
| 06/21/2006 | EP1670434A1 Methods for preparing oil bodies comprising active ingredients |
| 06/21/2006 | EP1670427A2 Methods and reagents for the treatment of immunoinflammatory disorders |
| 06/21/2006 | EP1506193B1 Carbamate-substituted pyrazolopyridines |
| 06/21/2006 | EP1482968B1 Treatment of type i diabetes mellitus using growth hormone antagonist |
| 06/21/2006 | EP1463797A4 Methods of kidney transplantation utilizing developing nephric tissue |
| 06/21/2006 | EP1463504B1 Compositions comprising epothilones and their use for the treatment of the carcinoid syndrome |
| 06/21/2006 | EP1448753B1 Conditioning solution for contact lenses |
| 06/21/2006 | EP1443915B1 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
| 06/21/2006 | EP1423147B1 Prostaglandin compositions and methods of treatment for male erectile dysfunction |
| 06/21/2006 | EP1401415B1 Use of n-phenyl-2-pyrimidine-amine derivatives for treating inflammatory diseases |
| 06/21/2006 | EP1365766B1 Pharmaceutical composition for treatment of phimosis using topical corticosteroid |
| 06/21/2006 | EP1345624B1 Induction of tolerance |
| 06/21/2006 | EP1326595B1 Pharmaceutical composition comprising resveratrol for treating inflammatory respiratory disorders |
| 06/21/2006 | EP1305047B1 Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection |
| 06/21/2006 | EP1305020B1 Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure |
| 06/21/2006 | EP1303306B1 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 06/21/2006 | EP1276476B1 Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations |
| 06/21/2006 | EP1267866B1 The treatment of respiratory diseases |
| 06/21/2006 | EP1263440B1 Cephalotaxine alkaloid combination compositions and uses thereof |
| 06/21/2006 | EP1251850B1 Use of a combination preparation in cancer therapy |
| 06/21/2006 | EP1250321B1 Glyburide composition |
| 06/21/2006 | EP1227810B1 Treating cancer by increasing intracellular malonyl coa levels |
| 06/21/2006 | EP1200094B1 Ophthalmic compositions containing antibiotics and nsaids |
| 06/21/2006 | EP1192185B1 Apo-2L RECEPTOR AGONIST AND CPT-11 SYNERGISM |
| 06/21/2006 | EP1146872B1 Use of angiotensin ii receptor antagonists for treating acute myocardial infarction |
| 06/21/2006 | CN1791440A Medical devices with enhanced ultrasonic visibility |
| 06/21/2006 | CN1791432A Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine |
| 06/21/2006 | CN1791430A Therapeutic combinations of atypical antipsychotics with GABA modulators, anticonvulsants or benzodiazapines |
| 06/21/2006 | CN1791429A Composition comprising a PDE4 inhibitor and a PDE5 inhibitor |
| 06/21/2006 | CN1791428A Preventives/remedies for snore or respiratory disturbances during sleep |
| 06/21/2006 | CN1791423A Treatment of alzheimer's disease |
| 06/21/2006 | CN1791410A Methods for treating or preventing an inflammatory or metabolic condition by inhibiting JNK |
| 06/21/2006 | CN1791408A Treatment of neurological conditions |
| 06/21/2006 | CN1791404A Antiarthritic combinations |
| 06/21/2006 | CN1791399A Methods for treating lower urinary tract disorders using smooth muscle modulators and alpha-2-delta subunit calcium channel modulators |